Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Longview, TX
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Longview, TX
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Ciudad de Buenos Aires,
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Ciudad de Buenos Aires,
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Dallas, TX
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
End of EXTEND: Observing for Sustained Response Despite Discontinuation of Medication in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Treated With Eltrombopag
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical College/New York Presbyterian Hospital
mi
from
New York, NY
End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
End of EXTEND: Observing for Sustained Response Despite Discontinuation of Medication in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Treated With Eltrombopag
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical College/New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital in Columbus
mi
from
Columbus, OH
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital in Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated:  12/31/1969
Hasbro Children's Hospital
mi
from
Providence, RI
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated: 12/31/1969
Hasbro Children's Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated:  12/31/1969
American Family Children's Hospital
mi
from
Madison, WI
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated: 12/31/1969
American Family Children's Hospital
mi
from
Madison, WI
Click here to add this to my saved trials
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
mi
from
Washington,
Corticosteroids for Children With Febrile Urinary Tract Infections
Corticosteroids for Children With Febrile Urinary Tract Infections
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Bronx-Lebanon Hospital Center NICHD CRS
mi
from
Bronx, NY
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Bronx-Lebanon Hospital Center NICHD CRS
mi
from
Bronx, NY
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Chapel Hill CRS
mi
from
Chapel Hill, NC
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Chapel Hill CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Columbia P&S CRS
mi
from
New York, NY
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Columbia P&S CRS
mi
from
New York, NY
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Denver Public Health CRS
mi
from
Denver, CO
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Denver Public Health CRS
mi
from
Denver, CO
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA CRS
mi
from
Torrance, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Houston AIDS Research Team CRS
mi
from
Houston, TX
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Houston AIDS Research Team CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
New Jersey Medical School Clinical Research Center CRS
mi
from
Newark, NJ
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
New Jersey Medical School Clinical Research Center CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Northwestern University CRS
mi
from
Chicago, IL
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Northwestern University CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Nyu Ny Nichd Crs
mi
from
New York, NY
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Nyu Ny Nichd Crs
mi
from
New York, NY
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
The University of Miami AIDS Clinical Research Unit (ACRU) CRS
mi
from
Miami, FL
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
The University of Miami AIDS Clinical Research Unit (ACRU) CRS
mi
from
Miami, FL
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Trinity Health and Wellness Center CRS
mi
from
Dallas, TX
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Trinity Health and Wellness Center CRS
mi
from
Dallas, TX
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
University of Southern California CRS
mi
from
Los Angeles, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
University of Southern California CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
University of Washington AIDS CRS
mi
from
Seattle, WA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
University of Washington AIDS CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Boston Medical Center CRS
mi
from
Boston, MA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Boston Medical Center CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Duke University Medical Center CRS
mi
from
Durham, NC
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Duke University Medical Center CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Gaborone CRS
mi
from
Gaborone,
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Gaborone CRS
mi
from
Gaborone,
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
mi
from
La Jolla, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
mi
from
La Jolla, CA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Decatur, GA
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chula Vista, CA
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Escondido, CA
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Escondido, CA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oceanside, CA
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Augusta, GA
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Waterloo, IA
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Waterloo, IA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Topeka, KA
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New Orleans, LA
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Royal Oak, MI
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bronx, NY
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mineola, NY
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials